The U.S. Food and Drug Administration (FDA) is facing growing attention over how it evaluates Rare Disease Therapies in 2026. Discussions around FDA Advisory Committees (AdComms) and patient-focused decision-making highlight a broader regulatory transformation that may reshape how pharmaceutical companies
The FDA has paused the public release of new Complete Response Letters (CRLs) while reviewing a citizen petition that challenges the legal basis of the disclosure program. The decision temporarily interrupts one of the agency’s most significant transparency initiatives and
This article explores how pharma regulatory bodies such as FDA, EMA, and WHO shape global GMP compliance. It highlights inspection trends, data integrity requirements, and harmonized regulatory frameworks that drive pharmaceutical quality systems and inspection readiness worldwide.
The pharmaceutical industry is under growing scrutiny from regulators when it comes to CAPA effectiveness checks. This blog explores how to improve root cause analysis, ensure closed-loop CAPA systems, and avoid repeat findings in GMP audits.
Understanding how clinical trials for medical devices are designed, conducted, and evaluated is critical in a highly regulated market. Here’s a clear, current, and professional look into the world of medical device clinical trials in 2025.
The landscape of drug pricing in the United States is currently undergoing a period of significant and unprecedented change, marked by potentially transformative reforms. This blog post delves into the intricacies of several key initiatives that are reshaping the pharmaceutical
Isolators and RABS both play critical roles in modern aseptic manufacturing, but their regulatory expectations differ significantly. FDA, EU, and ISO guidelines emphasize risk-based design, validated control measures, and procedural discipline.
Pharmaceutical isolators have revolutionized aseptic manufacturing by offering a controlled, contamination-free environment that enhances both product safety and operator protection.
Explore and uncover the key aspects of efficient pharmaceutical internal audit processes, while also delving into the valuable ISO 19011 guidelines. Understand the importance of thorough audit program preparation, as it is essential for achieving success in your auditing efforts
